Abstract:Matrix metalloproteinases (MMPs) are regarded as a significant regulator in tumor invasion and metastasis. Previous studies have shown that extracellular matrix metalloproteinase inducer (EMMPRIN) in tumor cells induces the synthesis of MMPs. EMMPRIN is abundantly present on the surface of tumor cells and stimulate adjacent stromal cells to synthesize MMPs to induce tumor progression. Giant cell tumor (GCT) of bone is a benign but locally aggressive primary neoplasm of bone. The spindle-shaped mononuclear stromal cells are considered to be the tumor components of GCT, which are capable of inducing osteoclast formation by recruiting the circulating monocyte and macrophage. In this study, we proposed that EMMPRIN is associated with the biological progression and aggressiveness of GCT. We have conducted semi-quantitative RT-PCR to determine the correlation of EMMPRIN expression with the clinical stage of GCT. We have also examined the cellular localization of EMMPRIN in GCT using in-situ hybridization (ISH) and Immunohistochemistry (IH). The results showed that EMMPRIN was present in GCT and its mRNA levels were associated with the clinical stage of GCT. Higher expression level of EMMPRIN was observed in GCT with advanced stage (stage III). There was a great significance (P < 0.05) of EMMPRIN expression between stage I & II and stage III GCTs. Both ISH and IH demonstrated that EMMPRIN is present at the multinuclear osteoclast-like giant cells of GCT, with strong immunostaining on the cell membrane. The stromal-like tumor cells were also positively stained but the intensity was weaker. Interestingly, the production of EMMPRIN in osteoclast-like cells of GCT seems to be regulated by stromal-like tumor cells. Receptor activator of NF-kappaB ligand (RANKL), which has been previously shown to be produced by the stromal-like tumor cells for the recruitment of osteoclast-like giant cells in GCT, enhanced the expression of EMMPRIN mRNA during the differentiation of macrophage-like RAW(264.7) cells into osteoclasts. In short, our studies suggest that EMMPRIN may be an important regulatory factor involved in the biological behaviors of GCT. (C) 2003 Wiley-Liss, Inc.

[Expression of ADAM12 (Meltrin-Alpha) Gene in Giant Cell Tumor of Bone].

The Expression of ADAM12 (meltrin Alpha) in Human Giant Cell Tumours of Bone.

Expression of ADAMTS12 in Colorectal Cancer-Associated Stroma Prevents Cancer Development and is a Good Prognostic Indicator of Colorectal Cancer

[Expression of a Disintegrin-Like and Metalloproteinase Protein 8 and 12 in the Giant Cell Lesions of Jaw].

[Expression of Macrophage Inflammatory Protein-1Alpha, a Disintegrin-Like and Metalloproteinase 8 and 12, and CD68 Protein in Giant Cell Lesions of Jaw and Giant Cell Tumors of Long Bone].

Expression And Localization Of Extracellular Matrix Metalloproteinase Inducer In Giant Cell Tumor Of Bone

Expression of CD147, PCNA, VEGF, MMPs and Their Clinical Significance in the Giant Cell Tumor of Bones.

Serglycin Induces Osteoclastogenesis and Promotes Tumor Growth in Giant Cell Tumor of Bone.

Gene Expression Disparity in Giant Cell Tumor of Bone

Nature of multinucleated giant cells in giant cell tumor and giant cell granuloma of the jaws

Expression and Significance of CD105 ,MMP-2 and MMP-9 in Giant Cell Tumor of Bone

Genome-Wide Transcriptome Profiling Of The Neoplastic Giant Cell Tumor Of Bone Stromal Cells By Rna Sequencing

Gene Expression of Osteoprotegerin and Osteoclast Differentiation Factor in Giant Cell Tumor

Expression and Significance of Ets-1, C-Myc in Giant Cell Tumor of Bone

The Expressions of Matrix Metalloproteinase-2 in Giant Cell Tumors of Bone and Its Significance

Immunohistochemical Study of Association of Angiogenesis and Expression of TGFβ_1 and TGFβ_3 with Prognosis in Giant Cell Tumor of Bone

Expressions of Annexina1, 14-3-3 Protein Ε and Peroxiredoxin 1 in Giant Cell Tumor of Bone

Expression of Matrix Metalloproteinase‐9 and CD34 in Giant Cell Tumor of Bone

Histological and clinical characteristics of malignant giant cell tumor of bone

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma

Benign Giant Cell of Bone:Marginal Biologic Behavior and Significan ce of SMAa Microvascular Marking